Filter
279
Text search:
drug
prices
Featured
Recommendations
26
New Publications
70
Language
Document type
No document type
156
Studies & Reports
66
Guidelines
31
Strategic & Response Plan
13
Manuals
7
Situation Updates
3
Resource Platforms
2
Fact sheets
1
Countries / Regions
Global
16
India
11
Western and Central Europe
9
Kenya
7
South Africa
7
Uganda
6
Malawi
5
Latin America and the Carribbean
5
Senegal
4
Ghana
4
Zambia
4
Syria
4
Myanmar / Burma
4
Eastern Europe
4
Sierra Leone
3
Nigeria
3
Cameroon
3
Zimbabwe
3
Philippines
3
Nepal
3
Cambodia
3
Rwanda
3
Bangladesh
3
Ukraine
3
Botswana
3
Africa
3
Liberia
2
Congo, Democratic Republic of
2
Ethiopia
2
Tanzania
2
Mozambique
2
South–East Asia Region
2
Asia
2
Venezuela
2
Tajikistan
2
South Sudan
1
Afghanistan
1
Lebanon
1
Thailand
1
Namibia
1
Lesotho
1
Middle East and North Africa
1
Albania
1
Southern Africa
1
Estonia
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
99
Clinical Guidelines
29
Public Health
16
Key Resources
11
Pharmacy & Technologies
11
Women & Child Health
7
Capacity Building
2
Toolboxes
HIV
43
Mental Health
24
TB
19
AMR
16
COVID-19
16
Pharmacy
15
Global Health Education
7
Conflict
6
NCDs
6
Health Financing Toolbox
5
Disability
4
NTDs
4
Refugee
3
Planetary Health
3
Polio
2
Rapid Response
2
Caregiver
2
Malaria
2
Ebola & Marburg
1
Natural Hazards
1
2.0 Rapid Response
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Policy Note #4: Myanmar Health Systems in Transition Policy Notes Series
Protecting people from financial hardship when they fall ill is one of the two key elements of universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government ...
Protecting people from financial hardship when they fall ill is one of the two key elements of universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government ...
The rise of the discourse of 'trauma' as a major articulator of suffering within Western culture is a facet of the medicalization of life that has gathered pace in the last century. In recent years, Western mental health professionals have been increasingly involved in services addressing the plight
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
Towards the Peoples Health Assembly Book -4
Policy Brief
Accessed: 20.11.2019
17–24 November 2015
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Strengthening HIV prevention among most-at-risk populations (MARPs) in the Syrian Arab Republic:
2nd edition. Essential guideline for humanitarian assistance
